Elevated IL-6 correlates with poor GC prognosis and activates JAK/STAT3 signaling to enhance proliferation, invasion, and lymphangiogenesis [28,29], underscoring the clinical relevance of our mechanistic insights. Here, STAT3 is linked to gastric cancer.